Initiation of ACESO’s COVID-19 adaptive platform trial (PROTECT-APT) received FDA approval. FHI Clinical is the CRO and IND sponsor across sites internationally
Tiziana and FHI Clinical enter a collaboration agreement for a phase 2 clinical trial of intranasal Foralumab to treat hospitalized patients with severe COVID-19
February 2, 2023
Oracle is supporting CROs with no-obligation access to its Clinical One platform through its CRO Growth Initiative. Read why we chose the platform as our default eClinical system.
January 30, 2023
Members of the PREVAIL team, with their research partners, recently published results from clinical trials of three vaccine regimens against Zaire Ebola virus disease (EVD).